Dr. Miguel Mauricio Cabada, MD, MS

Dr. Cabada practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Cabada's NPI, 1255532982, was assigned on May 30, 2007. Dr. Cabada graduated from Cayetano Heredia University in 2000. Dr. Cabada holds Texas license 44949.

Dr. Cabada's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Cabada's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. Dr. Cabada is also affiliated with John Sealy Hospital. The medical group on file is UTMB Faculty Group Practice.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cabada practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Cabada's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Cabada is board certified in infectious disease by the American Board of Internal Medicine. Dr. Cabada is licensed in Texas.

CMS data shows 55 Medicare services from Dr. Cabada across 2 procedure codes in 2024, for 33 Medicare patients. Medicare paid $4,241 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 33 Medicare patients who saw Dr. Cabada in 2024. The largest group is 65 to 74, with 14 patients. 75% of them have high blood pressure, and 73% have high cholesterol. Their average risk score is 3.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cabada's median patient age at 67, with 50% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Cabada for performance year 2024, reported as part of a group. Dr. Cabada accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 52 papers to Dr. Cabada, published from 2008 to 2025. 2024 was the busiest year, with 8. The most frequent topics are Peru, Fascioliasis and Fasciola hepatica. Dr. Cabada has published most often in Am J Trop Med Hyg. Dr. Cabada's most frequent co-authors are Peter C. Melby, Chelsey Anne Bravenec, MD and Brittany Anne Bunag, MD.

CMS Open Payments shows 2 general payments to Dr. Cabada from 2 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Sanofi Pasteur Inc. paid the most, $121.

Dr. Cabada graduated from Cayetano Heredia University in 2000.

Dr. Cabada is in network with 22 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.